ASEAN MedTech Insights
Pure Global's ASEAN MedTech Insights: Mastering Vietnam's Regulatory Maze from Decree 98 to Decree 07 for Market Success.
17 Oct 2025
In this episode of ASEAN MedTech Insights, we unravel the complex regulatory web governing medical devices in Vietnam. We provide a deep dive into the foundational Decree 98/2021, the detailed implementation guide of Circular 05/2022, and the critical deadline extensions provided by Decree 07/2023. This is a must-listen for any MedTech company currently in or planning to enter the fast-growing Vietnamese market. We break down what these changes mean for your product registration, documentation, and overall market access strategy, moving beyond legal jargon to provide actionable insights. Imagine being a manufacturer of a Class C diagnostic device, with your Vietnamese import license about to expire. The new regulations demand a complex technical dossier in a format your team has never prepared, and the deadline is fast approaching. A single mistake in the submission could lead to rejection, halting your sales and severing relationships with local distributors. This episode walks you through how to navigate this exact scenario. Key Takeaways: * What fundamental shift did Decree 98/2021 introduce to Vietnam's medical device approval process? * How does Circular 05/2022 specify the dossier requirements for high-risk devices? * Why was Decree 07/2023 considered a critical lifeline for foreign manufacturers? * What are the most common pitfalls when preparing a Common Submission Dossier Template (CSDT) for the Vietnamese authorities? * How can you effectively manage the transition from an old import license to a new marketing authorization number? * What are the current, final deadlines that your company absolutely cannot miss? * What role does a local license holder play under the new regulatory framework? Navigating ASEAN's regulatory environment requires specialized local knowledge and a global perspective. Pure Global offers end-to-end regulatory consulting solutions for MedTech and IVD companies, leveraging local expertise and advanced AI tools to streamline your market access. From initial regulatory strategy and technical dossier submission to post-market surveillance, we act as your single partner for multiple markets. Contact us for a strategic consultation at [email protected] or visit https://pureglobal.com/.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
3ª PARTE | 17 DIC 2025 | EL PARTIDAZO DE COPE
01 Jan 1970
El Partidazo de COPE
TNB Tech Minute: FTC Orders Instacart to Pay $60 Million Over Deceptive Practices
18 Dec 2025
WSJ Tech News Briefing
Hidden Gem Stocks We Love at the End of the Year
18 Dec 2025
Motley Fool Money
Google Undercuts the Field, OpenAI Builds an App OS, and China Accelerates
18 Dec 2025
The Daily AI Show
Lucy Liu
18 Dec 2025
Fresh Air
#2428 - Michael P. Masters
18 Dec 2025
The Joe Rogan Experience